Hanmi Pharm Partners with Suppliers for Mutual Growth... Launches Mentorship Program

About 50 Partners Attendees

Hanmi Pharm announced on the 22nd that it held the "3rd Hanmi Pharm Partner Mentorship Program" on the theme of "ESG and Sustainable Supply Chain Strategy" at its headquarters in Songpa-gu, Seoul on the 14th.

The event was attended by 57 representatives from 38 companies, including Hanmi Pharm's raw material partners such as Inist ST, Haeden Design Plus, and KP Tech. Park Jinhwa, an officer from the Gyeonggi Small and Medium Business Administration, was invited as a guest lecturer.

The program consisted of four sessions: ▲ Explanation of the ESG (Environmental, Social, and Governance) supply chain due diligence process ▲ Briefing on the delivery price linkage system ▲ Introduction of excellent development cases ▲ Discussion on partner compliance strategies. Hanmi Pharm introduced the current status of ESG management and the European Union (EU) supply chain due diligence system, and explained compliance strategies to promote fair trade compliance and ethical management awareness among companies.

During the mentorship, there was also a presentation of cases of companies with outstanding achievements in technology research and development, along with an award ceremony. Joongsuk Medipl, a specialized medical container manufacturer, was selected as an excellent product development company for applying its self-developed eye drop container to Hanmi Pharm’s multi-use eye drops, enhancing usability and convenience. Joongsuk Medipl’s container is designed to allow the appropriate amount of eye drops to be dispensed with minimal force, improving user convenience. It also applies a shrink packaging method that is resistant to external contamination, thereby increasing safety.

Kim Mingyeol, head of Joongsuk Medipl, said, "We are very pleased that Joongsuk Medipl was selected as an excellent development company in this mentorship program. As the number one domestic eye drop container company boasting state-of-the-art facilities, we will continue to focus on product development to contribute to the localization of eye drops through ongoing cooperation with Hanmi Pharm."

A Hanmi Pharm official stated, "One of the core aspects of practicing ESG management is co-growth with partners. We will fulfill our social responsibilities by prioritizing sustainable win-win cooperation through systematic and warm supply chain management."

This content was produced with the assistance of AI translation services.